A fixed dose combination of ibuprofen and famotidine

被引：4

作者：

Birk, John W. ^{[1
]}

Myers, Matthew ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2009年 / 18卷 / 09期

关键词：

famotidine; H2 receptor antagonist; ibuprofen; NSAID; pain; peptic ulcer; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTRODUODENAL DAMAGE; RHEUMATOID-ARTHRITIS; DUODENAL-ULCERS; DOUBLE-BLIND; CLINICAL PHARMACOKINETICS; PREVENTION; RANITIDINE; ENANTIOMERS; MISOPROSTOL;

D O I：

10.1517/13543780903160641

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The NSAID class of medications is frequently used for mild to moderate pain. While overall safe, NSAIDs have several important adverse effects including esophageal, gastric and duodenal ulceration which limit their use. This has led to the development of NSAIDs with either less gastrointestinal side effects or concurrent use of medications to prevent NSAID gastrointestinal side effects. While several classes of medications exist for the prevention of gastrointestinal side effects, few combination treatments are available in a single pill. Towards this end, a combination pill of ibuprofen and famotidine (HZT-501, Horizon Therapeutics, Skokie, IL. USA) has been developed.

引用

页码：1385 / 1391

页数：7

共 56 条

[1]

AABAKKEN L, 1990, ALIMENT PHARM THER, V4, P295

[2] SOME BIOLOGICAL PROPERTIES OF 2-(4-ISOBUTYLPHENYL)-PROPIONIC ACID [J].

ADAMS, SS ;

CLIFFE, EE ;

LESSEL, B ;

NICHOLSON, JS .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (12) :1686-+

[3]

Adams SS, 1970, RHEUMATOL PHYS M S10, V10, P9

[4] MISOPROSTOL COMPARED WITH SUCRALFATE IN THE PREVENTION OF NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED GASTRIC-ULCER - A RANDOMIZED, CONTROLLED TRIAL [J].

AGRAWAL, NM ;

ROTH, S ;

GRAHAM, DY ;

WHITE, RH ;

GERMAIN, B ;

BROWN, JA ;

STROMATT, SC .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (03) :195-200

[5]

[Anonymous], 2008, COCHRANE DATABASE SY

[6]

BAILLIE TA, 1989, J PHARMACOL EXP THER, V249, P517

[7] Cycloxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation [J].

Chen, Y-F ;

Jobanputra, P. ;

Barton, P. ;

Bryan, S. ;

Fry-Smith, A. ;

Harris, G. ;

Taylor, R. S. .

HEALTH TECHNOLOGY ASSESSMENT, 2008, 12 (11) :1-+

[8] PHARMACOKINETICS AND BIOINVERSION OF IBUPROFEN ENANTIOMERS IN HUMANS [J].

CHENG, HY ;

ROGERS, JD ;

DEMETRIADES, JL ;

HOLLAND, SD ;

SEIBOLD, JR ;

DEPUY, E .

PHARMACEUTICAL RESEARCH, 1994, 11 (06) :824-830

[9]

Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308

[10] USE OF MICROBLEEDING AND AN ULTRATHIN ENDOSCOPE TO ASSESS GASTRIC-MUCOSAL PROTECTION BY FAMOTIDINE [J].

DANESHMEND, TK ;

PRICHARD, PJ ;

BHASKAR, NK ;

MILLNS, PJ ;

HAWKEY, CJ .

GASTROENTEROLOGY, 1989, 97 (04) :944-949

← 1 2 3 4 5 6 →